From: MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer
Half-life
Tmax
Cmax
Clast
AUCall
AUCINF_obs
CL
Vss
(h)
(ug/mL)
(ug h/mL)
(mL/h/kg)
(mL/kg)
MEDI3039
15.4
0.25
130.76
0.06
828.9
830.84
7.82
79.71